---
title: "Decoy Therapeutics Inc. (DCOY.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/DCOY.US.md"
symbol: "DCOY.US"
name: "Decoy Therapeutics Inc."
industry: "Biotechnology"
datetime: "2026-05-21T11:56:10.875Z"
locales:
  - [en](https://longbridge.com/en/quote/DCOY.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/DCOY.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/DCOY.US.md)
---

# Decoy Therapeutics Inc. (DCOY.US)

## Company Overview

Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company. It focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that leverages peptide coiled-coils chemistry and physics to design a-helical peptides through computational and ML tools. The company’s IMP3ACT platform leverages machine learning and artificial intelligence tools alongside synthesis techniques to engineer, enhance, and manufacture peptide conjugates targeting various unmet medical needs.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | US Market |
| Website | [decoytx.com](https://decoytx.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.23 | 95 | - | - | - |
| PB | 0.76 | 63 | 1.38 | 1.06 | 0.71 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-01-23T05:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 5.56 |
| Highest Target | 30.00 |
| Lowest Target | 30.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/DCOY.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/DCOY.US/norm.md)
- [Related News](https://longbridge.com/en/quote/DCOY.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/DCOY.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**